Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gahan J Pandina

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Child and Adolescent Psychopharmacology|December 29, 2009
Cognitive function with long-term risperidone in children and adolescents with disruptive behavior disorderGahan J Pandina, Young Zhu, Barbara Cornblatt
Journal of Child and Adolescent Psychopharmacology|September 2, 2008
Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescentsMagali Haas, Keith Karcher, Gahan J Pandina
Journal of Child and Adolescent Psychopharmacology|September 9, 2006
Risperidone in the management of disruptive behavior disordersGahan J Pandina, Michael G Aman, Robert L Findling
Administration and Policy in Mental Health|November 4, 2006
Direct health care costs for children with pervasive developmental disorders: 1996-2002Scott C Flanders, Luella Engelhart, Gahan J Pandina, et al.
Child and Adolescent Psychiatry and Mental Health|August 9, 2007
Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TDGahan J Pandina, Cynthia A Bossie, Young Zhu, et al.
Journal of Autism and Developmental Disorders|October 5, 2006
Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trialGahan J Pandina, Cynthia A Bossie, Eriene Youssef, et al.
European Child & Adolescent Psychiatry|November 1, 2006
Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trialsPeter S Jensen, Jan Buitelaar, Gahan J Pandina, et al.
Human Psychopharmacology|June 30, 2007
Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophreniaGahan J Pandina, Carla M Canuso, Eriene Youssef, et al.
BMC Medicine|July 2, 2008
Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded studyRohan Ganguli, Jaspreet S Brar, Ramy Mahmoud, et al.
Psychopharmacology Bulletin|November 17, 2007
Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trialGahan J Pandina, Carla M Canuso, Ibrahim Turkoz, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Child and Adolescent Psychopharmacology|December 29, 2009
Cognitive function with long-term risperidone in children and adolescents with disruptive behavior disorderGahan J Pandina, Young Zhu, Barbara Cornblatt
Journal of Child and Adolescent Psychopharmacology|September 2, 2008
Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescentsMagali Haas, Keith Karcher, Gahan J Pandina
Journal of Child and Adolescent Psychopharmacology|September 9, 2006
Risperidone in the management of disruptive behavior disordersGahan J Pandina, Michael G Aman, Robert L Findling
Administration and Policy in Mental Health|November 4, 2006
Direct health care costs for children with pervasive developmental disorders: 1996-2002Scott C Flanders, Luella Engelhart, Gahan J Pandina, et al.
Child and Adolescent Psychiatry and Mental Health|August 9, 2007
Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TDGahan J Pandina, Cynthia A Bossie, Young Zhu, et al.
Journal of Autism and Developmental Disorders|October 5, 2006
Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trialGahan J Pandina, Cynthia A Bossie, Eriene Youssef, et al.
European Child & Adolescent Psychiatry|November 1, 2006
Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trialsPeter S Jensen, Jan Buitelaar, Gahan J Pandina, et al.
Human Psychopharmacology|June 30, 2007
Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophreniaGahan J Pandina, Carla M Canuso, Eriene Youssef, et al.
BMC Medicine|July 2, 2008
Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded studyRohan Ganguli, Jaspreet S Brar, Ramy Mahmoud, et al.
Psychopharmacology Bulletin|November 17, 2007
Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trialGahan J Pandina, Carla M Canuso, Ibrahim Turkoz, et al.
Pageof 3